Blog

Check out the most recent corporate news from uFluidix as well as latest research in the domain of microfluidics.

Advancing Tuberculosis Therapy with Microfluidic Technology

Tuberculosis (TB) remains one of the most persistent global health threats, primarily due to the ability of Mycobacterium tuberculosis (Mtb) to develop drug resistance and persist in the host for extended periods. The slow and grueling treatment process, often marred by relapse, underscores the urgent...